Results 1 to 10 of about 2,377,916 (241)

Safety and interaction of direct oral anticoagulants with antiarrhythmic drugs [PDF]

open access: yesРоссийский кардиологический журнал, 2021
The use of direct oral anticoagulants minimized the risks associated with vitamin K antagonist (warfarin) therapy. Currently, direct oral anticoagulants have priority over warfarin for the prevention of thromboembolic events in patients with atrial ...
B. A. Tatarsky, N. V. Kazyonnova
doaj   +2 more sources

Antiarrhythmic therapy for narrow QRS supraventricular tachyarrhythmias in newborns and infants in the first year of life: Potent tools to be handled with care [PDF]

open access: yesIndian Pacing and Electrophysiology Journal
Supraventricular tachyarrhythmias pose a significant challenge in neonates and infants, particularly within the first year of life, where prompt and effective management is crucial.
Giovanni Domenico Ciriello   +13 more
doaj   +2 more sources

Revisiting Antiarrhythmic Drug Therapy for Atrial Fibrillation: Reviewing Lessons Learned and Redefining Therapeutic Paradigms

open access: yesFrontiers in Pharmacology, 2020
Since the clinical use of digitalis as the first pharmacological therapy for atrial fibrillation (AF) 235 years ago in 1785, antiarrhythmic drug therapy has advanced considerably and become a cornerstone of AF clinical management.
Meng Geng, Andrew Lin, Thao P. Nguyen
doaj   +3 more sources

Antiarrhythmic therapy in pregnancy

open access: yesКлинический разбор в общей медицине
Arrhythmia is a common cardiovascular disease (CVD) that can lead to hemodynamic instability, worsening the pregnant woman’s condition (gestosis, threatened miscarriage, placental abruption, pregnancy loss, fetal hypoxia), the fetus’s condition ...
Khafiza G. Alidzhanova   +4 more
doaj   +2 more sources

Antiarrhythmic drug therapy in the neonate

open access: yesProgress in Pediatric Cardiology, 2000
The neonate presents a challenge for the practitioner considering antiarrhythmic therapy: pharmacokinetics are different than in older children or adults; and the arrhythmia substrate may also differ, with respect to issues of ion channel and autonomic nervous system development.
exaly   +3 more sources

EFFECT OF SPIRAPRIL ON THE LENGTH OF INTERICTAL INTERVAL IN PAROXYSMAL ATRIAL FIBRILLATION

open access: yesРациональная фармакотерапия в кардиологии, 2015
Aim. To evaluate effects of angiotensin converting enzyme inhibitor spirapril on efficacy of preventive antiarrhythmic therapy in patients with paroxysmal atrial fibrillation (AF).Material and methods. 40 patients with paroxysmal AF were involved in open-
L. N. Chikhireva   +3 more
doaj   +3 more sources

Efficacy and Safety of Catheter Ablation vs Antiarrhythmic Drugs as Initial Therapy for Management of Symptomatic Paroxysmal Atrial Fibrillation: A Meta-Analysis

open access: yesReviews in Cardiovascular Medicine, 2022
Background: Catheter ablation is an effective treatment for atrial fibrillation (AF), primarily performed in patients who fail antiarrhythmic drugs. Whether early catheter ablation, as first-line therapy, is associated with improved clinical outcomes ...
Aminah Abdul Razzack   +16 more
doaj   +1 more source

Zero-fluoroscopy approach for ablation in Wolf -Parkinson – White syndrome during pregnancy

open access: yesHeart Vessels and Transplantation, 2022
Paroxysmal supraventricular tachycardias during pregnancy are rare; however, it can be a therapeutic challenge because of limitations about use of antiarrhythmic drug therapy and catheter ablation indication, due to the risk of radiation exposure to the ...
Ulises Rojel   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy